Gateway Clinical Trials | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout	Hyperuricemia, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Recruiting	Phase 3	2026-09-28		NCT07089888
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder	Recruiting	Phase 3	2026-09-28		NCT07089875
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder	Recruiting	Not applicable	2026-02-17		NCT05758545
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers	Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder	Recruiting	Phase 1 / Phase 2	2026-02-12		NCT07396376